BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27085543)

  • 1. Alteration of fatal 1:1 conducted atrial flutter to less conducted ratio by landiolol infusion.
    Takata J; Haruyama N; Arashi T; Mae T
    J Anesth; 2016 Aug; 30(4):716-9. PubMed ID: 27085543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of patient characteristics on the effectiveness of landiolol in AF/AFL patients complicated with LV dysfunction: Subgroup analysis of the J-Land study.
    Kinugawa K; Nagai R; Inoue H; Atarashi H; Seino Y; Yamashita T; Shimizu W; Aiba T; Kitakaze M; Sakamoto A; Ikeda T; Imai Y; Daimon T; Fujino K; Nagano T; Okamura T; Hori M;
    Adv Ther; 2014 Apr; 31(4):426-39. PubMed ID: 24643403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Effectiveness of Landiolol Between Atrial Fibrillation and Atrial Flutter/Atrial Tachycardia Patients With Left Ventricular Dysfunction.
    Oka E; Iwasaki YK; Maru E; Fujimoto Y; Ito-Hagiwara K; Hayashi H; Yamamoto T; Yodogawa K; Hayashi M; Shimizu W
    Circ J; 2019 Mar; 83(4):793-800. PubMed ID: 30814430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open-Label Two-Dose Pilot Study of Landiolol for the Treatment of Atrial Fibrillation/Atrial Flutter in Caucasian Patients.
    Stix G; Wolzt M; Domanovits H; Kadlecová P; Husch B; Trebs M; Hodisch J; Unger M; Krumpl G
    Circ J; 2019 Dec; 84(1):33-42. PubMed ID: 31813897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection.
    Nakano T; Shimizu K; Kawashima O; Kamiyoshihara M; Nagashima T; Ibe T; Takeyoshi I
    J Clin Pharm Ther; 2012 Aug; 37(4):431-5. PubMed ID: 22059486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study).
    Nagai R; Kinugawa K; Inoue H; Atarashi H; Seino Y; Yamashita T; Shimizu W; Aiba T; Kitakaze M; Sakamoto A; Ikeda T; Imai Y; Daimon T; Fujino K; Nagano T; Okamura T; Hori M;
    Circ J; 2013; 77(4):908-16. PubMed ID: 23502991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of a prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey.
    Yamashita T; Saitoh T; Matsushita M
    J Cardiol; 2015 Jul; 66(1):69-72. PubMed ID: 25454208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Experience of Landiolol Use for an Advanced Heart Failure Patient With Severe Hypotension.
    Nitta D; Kinugawa K; Imamura T; Endo M; Amiya E; Inaba T; Maki H; Hatano M; Komuro I
    Int Heart J; 2015; 56(5):564-7. PubMed ID: 26370372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of atrial fibrillation to sinus rhythm during landiolol infusion.
    Mayahara T; Goto M; Sato M; Kanazawa T; Isomine S; Nakajima H; Sakaida K
    J Anesth; 2004; 18(4):304-6. PubMed ID: 15549475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of atrial flutter to sinus rhythm during landiolol infusion.
    Yamamoto S; Goto K; Ohchi Y; Yasuda N; Shingu C; Noguchi T
    J Anesth; 2010 Feb; 24(1):107-9. PubMed ID: 20039082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery in patients with left ventricular dysfunction: Prevention of Atrial Fibrillation After Cardiac Surgery With Landiolol Hydrochloride for Left Ventricular Dysfunction (PLATON) trial.
    Sezai A; Osaka S; Yaoita H; Ishii Y; Arimoto M; Hata H; Shiono M
    J Thorac Cardiovasc Surg; 2015 Oct; 150(4):957-64. PubMed ID: 26254752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose.
    Wariishi S; Yamashita K; Nishimori H; Fukutomi T; Yamamoto M; Radhakrishnan G; Sasaguri S
    Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):811-3. PubMed ID: 19666952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey.
    Yamashita T; Nakasu Y; Mizutani H; Sumitani K
    J Cardiol; 2019 Nov; 74(5):418-425. PubMed ID: 31255463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of postoperative landiolol administration for atrial fibrillation after off pump coronary artery bypass surgery.
    Fujii M; Bessho R; Ochi M; Shimizu K; Terajima K; Takeda S
    J Cardiovasc Surg (Torino); 2012 Jun; 53(3):369-74. PubMed ID: 22249647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Landiolol and Digoxin as an Intravenous Drug for Controlling the Heart Rate in Patients with Atrial Fibrillation and Severely Depressed Left Ventricular Function.
    Shinohara M; Wada R; Yano K; Akitsu K; Koike H; Kinoshita T; Suzuki T; Fujino T; Ikeda T
    Int Heart J; 2020 Sep; 61(5):944-950. PubMed ID: 32921677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study design for control of HEART rate in inFant and child tachyarrhythmia with heart failure Using Landiolol (HEARTFUL): A prospective, multicenter, uncontrolled clinical trial.
    Sumitomo N; Horigome H; Miura M; Ono H; Ueda H; Takigiku K; Yoshimoto J; Ohashi N; Suzuki T; Sagawa K; Ushinohama H; Takahashi K; Miyazaki A; Sakaguchi H; Iwamoto M; Takamuro M; Tokunaga C; Nagano T;
    J Cardiol; 2017 Sep; 70(3):232-237. PubMed ID: 28073682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perioperative heart rate control with landiolol for a patient with rapid atrial fibrillation complicated with low cardiac function].
    Sakai H; Igarashi K; Imai M; Miura K; Kanai M; Okazaki A
    Masui; 2004 May; 53(5):555-8. PubMed ID: 15198243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of an ultrashort-acting β1-blocker on left ventricular dysfunction.
    Ito N; Tashiro T; Morishige N; Nishimi M; Hayashida Y; Minematsu N; Kuwahara G; Sukehiro Y; Teratani H
    Heart Surg Forum; 2012 Aug; 15(4):E189-94. PubMed ID: 22917822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
    Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Landiolol: A Review in Tachyarrhythmias.
    Syed YY
    Drugs; 2018 Mar; 78(3):377-388. PubMed ID: 29470800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.